Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Andrea Breglia
Tissue Inhibitor Metalloproteinase-2 (TIMP-2) • IGF-binding Protein-7 (IGFBP7) Levels Are Associated With Adverse Outcomes in Patients in the Intensive Care Unit With Acute Kidney Injury
Kidney International
Nephrology
Related publications
Acute Kidney Injury in Non-Intensive Care Unit and Intensive Care Unit Patients Treated With Vancomycin and Piperacillin-Tazobactam
Journal of Nippon Medical School
Medicine
Diagnostic Value of Urine Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 for Acute Kidney Injury: A Meta-Analysis
PLoS ONE
Multidisciplinary
Predictors of Mortality in Children With Acute Kidney Injury in Intensive Care Unit
Paediatrica Indonesiana
Utility of Trend of Nephrocheck® (IGFBP7 × TIMP-2) Biomarker for Early Identification of Acute Kidney Injury in Critically Ill Patients With Sepsis or Respiratory Failure
Journal of Clinical Nephrology and Renal Care
Diagnostic Prediction of Urinary [TIMP-2] X [IGFBP7] for Acute Kidney Injury: A Meta-Analysis Exploring Detection Time and Cutoff Levels
Oncotarget
Oncology
Clinical Use of [TIMP-2]•[IGFBP7] Biomarker Testing to Assess Risk of Acute Kidney Injury in Critical Care: Guidance From an Expert Panel
Critical Care
Critical Care
Intensive Care Medicine
Serum Tissue Inhibitor of Matrix Metalloproteinase-1 Levels Are Associated With Mortality in Patients With Malignant Middle Cerebral Artery Infarction
BMC Neurology
Medicine
Neurology
Diagnostic Power of Cytokine M-Csf, Metalloproteinase 2 (MMP-2) and Tissue Inhibitor-2 (TIMP-2) in Cervical Cancer Patients Based on ROC Analysis
Pathology and Oncology Research
Medicine
Forensic Medicine
Pathology
Oncology
Cancer Research
Dysregulated Mineral Metabolism in Patients With Acute Kidney Injury and Risk of Adverse Outcomes
Clinical Endocrinology
Endocrinology
Metabolism
Diabetes
